Laboratory Corporation Of America Trying To Close In On Key Technical Measure

The Relative Strength (RS) Rating for Laboratory Corporation Of America (LH) moved into a new percentile Friday, as it got a lift from 68 to 71.


When you’re researching the best stocks to buy and watch, be sure to pay attention to relative price strength.

IBD’s proprietary RS Rating tracks market leadership by showing how a stock’s price movement over the last 52 weeks measures up against that of the other stocks in our database.

Over 100 years of market history shows that the stocks that go on to make the biggest gains often have an RS Rating of above 80 in the early stages of their moves. See if Laboratory Corporation Of America can continue to show renewed price strength and clear that threshold.

See How IBD Helps You Make More Money In Stocks

Laboratory Corporation Of America is now considered extended and out of buy range after clearing a 218.87 buy point in a first-stage flat base. See if the stock forms a new chart pattern or follow-on buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week moving average.

In terms of fundamentals, Laboratory Corporation Of America has posted two quarters of accelerating earnings growth. Top line growth has also moved higher during the same period. The company is expected to release its next quarterly numbers on or around Apr. 29.

The company holds the No. 2 rank among its peers in the Medical-Services industry group. Laboratory Corporation Of America (LH) and Infusystem (INFU) are also among the group’s highest-rated stocks.


Which Stocks Are Showing Rising Relative Strength?

Why Should You Use IBD’s Relative Strength Rating?

How Relative Strength Line Can Help You Judge A Stock

Identify Bases And Buy Points With Pattern Recognition From MarketSmith

Most Related Links :
usnewsmail Governmental News Finance News

Source link

Back to top button